Year: 2022
Type: article
Abstract: Artificial intelligence (AI) is revolutionizing the pharmaceutical industry by expediting drug development, improving patient outcomes, and reducing the cost of drug discovery. AI is used to predict the safety, efficacy, and side effects of a drug, to optimize the dosages, and to identify new targets for drug development. AI algorithms are trained on large data sets, such as patient records, clinical trials, and genetic information, to identify patterns and correlations that can guide drug discovery and development. AI is also used to design and test drugs in silico, using computer simulations and virtual models, which can save time and resources compared to traditional laboratory experiments. Furthermore, AI-powered devices, such as wearable sensors and smart pills, can monitor patients' health status, adherence to medication, and disease progression, providing real-time data for personalized treatment. AI is also transforming clinical trials, by improving patient recruitment, stratification, and retention, and by reducing the risk of placebo effects and biases. The integration of AI with other technologies, such as blockchain and nanotechnology, can also enhance the security, traceability, and delivery of drugs. Overall, AI is transforming the pharmaceutical industry by accelerating innovation, improving efficiency, and advancing patient-centered care.
Author: Sruthi Nair
Institution: Rashtrasant Tukadoji Maharaj Nagpur University
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W7219052118
